🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an exploratory study evaluating CS0159 in combination with Semaglut...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-01
Trial ID
NCT07570810
Treatments Being Tested
A randomized, double-blind study to assess the safety, tolerability, PK and...
Status
Completed
Location
National Research Institute - Gardena
Start Date
2023-02-10
Trial ID
NCT05591079
Treatments Being Tested
A Randomized, Double-Blind, Placebo-controlled, Phase III Study to Evaluate...
Status
Recruiting
Location
The First Affiliated Hospital of USTC Anhui Provincial Hospital
Start Date
2025-12-01
Trial ID
NCT07282353
Treatments Being Tested
A phase II Study of CS0159 in Chinese patients with PSC(Primary Sclerosing ...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of USTC Anhui Provincial Hospital
Start Date
2023-08-07
Trial ID
NCT05896137
Treatments Being Tested
A phase II study to evaluate safety, tolerability and efficacy of CS0159 in...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of USTC Anhui Provincial Hospital
Start Date
2023-08-07
Trial ID
NCT05896124
Treatments Being Tested
This is an exploratory study evaluating CS0159 in combination with Semaglut...
Status
Completed
Location
Dep.endocrinology of Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2024-07-19
Trial ID
NCT06492330
Treatments Being Tested
This is a phase I clinical bridging trial, randomized, double-blind, placeb...
Status
Completed
Location
Shanghai Xuhui Central Hospital
Start Date
2022-12-19
Trial ID
NCT05624294
Study of \[14C\]CS0159 in China Healthy Subjects....
Status
Completed
Location
The First Affiliated Hospital of Soochow University
Start Date
2023-10-23
Trial ID
NCT06098027
Treatments Being Tested
Phase I Study of the Pharmacokinetics and Safety of CS0159 in Subjects With...
Status
Completed
Location
The First Affiliated Hospital of Soochow University
Start Date
2025-03-13
Trial ID
NCT06888115
Treatments Being Tested
The whole study includes 2 parts. Both the SAD study and MAD study are rand...
Status
Completed
Location
Labcorp Clinical Research Unit, Inc.
Start Date
2021-10-26
Trial ID
NCT05082779
Treatments Being Tested